ASKA Pharmaceutical Co., Ltd. Share Price Japan Exchange
Stocks
4514
JP3541200006
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.16TCr 39Cr 34Cr 32Cr 29Cr 55Cr 3.74TCr 55Cr 385.77Cr 148.86Cr 1.91TCr 146.97Cr 143.74Cr | P/E 2027 * |
13.2x | P/E 2028 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16TCr 39Cr 34Cr 32Cr 29Cr 55Cr 3.74TCr 55Cr 385.77Cr 148.86Cr 1.91TCr 146.97Cr 143.74Cr | EV / Sales 2027 * |
0.84x | EV / Sales 2028 * | 0.82x |
| Free-Float |
64.59% | Yield 2027 * |
3% | Yield 2028 * | 3.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tomohito Nagao
CEO | Chief Executive Officer | - | - |
Sota Yamaguchi
PSD | President | 42 | 24/06/2025 |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 24/06/2025 | |
Atsushi Maruo
BRD | Director/Board Member | 67 | 01/04/2021 |
Sota Yamaguchi
BRD | Director/Board Member | 42 | 01/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -4.29% | - | - | 39Cr | |
| +0.45% | +3.00% | +55.00% | +112.54% | 1,04300Cr | |
| -0.10% | +0.74% | +54.52% | +67.72% | 65TCr | |
| +0.28% | +0.82% | +19.15% | +73.63% | 47TCr | |
| -0.19% | +0.97% | +34.30% | +45.99% | 35TCr | |
| +0.28% | +2.30% | +18.47% | +26.67% | 27TCr | |
| +0.89% | +4.59% | +10.19% | +14.72% | 26TCr | |
| +4.34% | +9.21% | +43.44% | +53.25% | 22TCr | |
| +1.40% | +4.35% | +35.72% | +103.53% | 19TCr | |
| -0.46% | -6.20% | -32.46% | -59.65% | 18TCr | |
| Average | +0.65% | +2.20% | +26.48% | +48.71% | 40.37TCr | |
| Weighted average by Cap. | +0.49% | +2.19% | +36.40% | +67.20% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 7.31TCr 46Cr 41Cr 38Cr 35Cr 65Cr 4.44TCr 65Cr 458.01Cr 176.73Cr 2.27TCr 174.48Cr 170.66Cr | 7.5TCr 48Cr 42Cr 39Cr 36Cr 67Cr 4.55TCr 67Cr 469.47Cr 181.16Cr 2.33TCr 178.85Cr 174.93Cr |
| Net income | 466.9Cr 2.97Cr 2.59Cr 2.44Cr 2.22Cr 4.17Cr 283.6Cr 4.17Cr 29Cr 11Cr 144.83Cr 11Cr 11Cr | 552.4Cr 3.51Cr 3.07Cr 2.88Cr 2.63Cr 4.94Cr 335.54Cr 4.94Cr 35Cr 13Cr 171.35Cr 13Cr 13Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
